FDA Approved Prepopik Bowel Prep Shows High Patient Tolerance

Prepopik, a low-volume bowel preparation for colonoscopies, received FDA approval last year and in the latest study of its use 58.4 percent of patients found the solution “very easy” to take, while 29 percent of patients found it “easy,” according to a Gastroenterology & Endoscopy News report.

Advertisement

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

The Ferring Pharmaceuticals prep, made of 10 grams of sodium picosulfate, 3.5 grams of magnesium oxide and 12 grams of citric acid, is to be administered in two five-ounce glasses and followed with clear liquids. Patients consume a total of two liters.  

More Articles on Gastroenterology:
UCLA Health System Opens New Specialty Services Practice, Including Gastroenterology
Gastrointestinal Device Market Estimated at $33B by 2023
FDA Grants 510(k) Clearance for Invendo Medical Single-Use Colonoscopy System

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.